BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12384436)

  • 1. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
    Molica S; Vacca A; Ribatti D; Cuneo A; Cavazzini F; Levato D; Vitelli G; Tucci L; Roccaro AM; Dammacco F
    Blood; 2002 Nov; 100(9):3344-51. PubMed ID: 12384436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Ricciotti A; Digiesi G
    Br J Cancer; 2002 Jan; 86(1):31-5. PubMed ID: 11857008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.
    Molica S
    Leuk Lymphoma; 2001 Aug; 42(4):603-7. PubMed ID: 11697488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
    Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Gandolfo GM; Liso V
    Br J Haematol; 1999 Dec; 107(3):605-10. PubMed ID: 10583266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
    Bairey O; Zimra Y; Shaklai M; Rabizadeh E
    Br J Haematol; 2001 May; 113(2):400-6. PubMed ID: 11380405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L; Kasparová P
    APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course.
    Osella-Abate S; Quaglino P; Savoia P; Leporati C; Comessatti A; Bernengo MG
    Melanoma Res; 2002 Aug; 12(4):325-34. PubMed ID: 12170181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
    Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
    Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
    Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
    Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
    Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
    Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
    Aguayo A; O'Brien S; Keating M; Manshouri T; Gidel C; Barlogie B; Beran M; Koller C; Kantarjian H; Albitar M
    Blood; 2000 Jul; 96(2):768-70. PubMed ID: 10887147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.
    Kini AR; Kay NE; Peterson LC
    Leukemia; 2000 Aug; 14(8):1414-8. PubMed ID: 10942237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.